BRD2 and Alzheimer disease: In humans, rising follicle-stimulating hormone (FSH) levels during menopause are associated with increased Aβ deposition in the frontal cortex and gray matter loss (76), implicating hypothalamic–pituitary–gonadal axis dysregulation in AD risk.